Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Overview of Exosomes

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Urolithin A activates mitophagy via the AMPK-mTOR axis and modulates the gut-ceramide axis to ameliorate cardiac remodeling in HFpEF.

Experimental & molecular medicine·2026

Same author

Clinical effectiveness and safety of laser lancing for heel puncture in preterm infants: a randomized crossover non-inferiority trial.

Journal of perinatology : official journal of the California Perinatal Association·2026

Same author

Safety and Radiological Outcomes of Posterior-Based Minimally Invasive Scoliosis Surgery in Young Adult Idiopathic Scoliosis: A Comparative Study Based on Age.

Operative neurosurgery (Hagerstown, Md.)·2026

Same author

Intercuneiform stabilization during a modified Lapidus procedure for hallux valgus results in decreased intercuneiform gapping and recurrence rates.

Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons·2026

Same author

Rotational Stability of Non-Engaging Abutments: Influence of Positioning Guide Thickness and Definitive Prosthesis Cement Space.

Journal of esthetic and restorative dentistry : official publication of the American Academy of Esthetic Dentistry ... [et al.]·2026

Same author

A distribution-level statistical framework for reliable pipeline leak detection using multi-domain signal analysis.

Scientific reports·2026

Search research articles

Related Experiment Video

Updated: Jul 31, 2025

Author Spotlight: Development of a Large-Scale, Reproducible Production Method for Exosome Mimetics Using Magnetic Nanoparticles

Author Spotlight: Development of a Large-Scale, Reproducible Production Method for Exosome Mimetics Using Magnetic Nanoparticles

Published on: January 26, 2024

Exosome-Based COVID-19 Vaccine.

Jaeyoung Kim¹, Nikita Thapa¹

¹CK Exogene, Inc., Seongnam, Gyeonggi do, Republic of Korea.

Methods in Molecular Biology (Clifton, N.J.)

|May 4, 2023

Summary

This study presents a novel vaccine strategy using engineered extracellular vesicles (EVs) to deliver SARS-CoV-2 antigens. These antigen-presenting EVs offer a safe and effective virus-free approach to stimulate robust immune responses.

Area of Science:

Immunology
Vaccinology
Biotechnology

Background:

Extracellular vesicles (EVs) facilitate cell-to-cell communication and antigen delivery, crucial for immune stimulation.
Current SARS-CoV-2 vaccines utilize viral vectors, mRNA, or purified proteins to deliver spike antigens.
There is a need for innovative, safe, and adaptable vaccine platforms.

Purpose of the Study:

To develop a novel vaccine approach using engineered exosomes to present SARS-CoV-2 antigens.
To evaluate the potential of engineered EVs as antigen-presenting vehicles for vaccine development.

Main Methods:

Engineering exosomes to encapsulate and present antigens derived from SARS-CoV-2 structural proteins.
Utilizing engineered EVs as antigen-presenting EVs to elicit immune responses.

Keywords:

Exosome-based vaccine Exosomes Extracellular vesicles Ultracentrifugation

More Related Videos

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

Related Experiment Videos

Last Updated: Jul 31, 2025

Author Spotlight: Development of a Large-Scale, Reproducible Production Method for Exosome Mimetics Using Magnetic Nanoparticles

Author Spotlight: Development of a Large-Scale, Reproducible Production Method for Exosome Mimetics Using Magnetic Nanoparticles

Published on: January 26, 2024

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

Main Results:

Engineered EVs effectively deliver viral antigens.
These EVs can elicit strong and targeted CD8(+) T cell and B cell responses.
Demonstrated potential for a virus-free vaccine development strategy.

Conclusions:

Engineered extracellular vesicles offer a promising, adaptable, and safe platform for virus-free vaccine development.
Antigen-presenting EVs can effectively stimulate key components of the adaptive immune system.
This novel methodology represents a unique approach to combating viral threats like SARS-CoV-2.